All Stories

  1. Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer’s Disease and Glaucoma: Present and Future Challenges
  2. Clotrimazole microemulsion and microemulsion-based gel: evaluation of buccal drug delivery and irritancy using chick chorioallantoic membrane as the model
  3. Ethosomes of Phenylethyl Resorcinol as Vesicular Delivery System for Skin Lightening Applications
  4. Microemulsion and Microemulsion-Based Gels for Topical Antifungal Therapy with Phytochemicals
  5. Design and characterization of chitosan/zeolite composite films — Effect of zeolite type and zeolite dose on the film properties
  6. Current nanotechnology approaches for the treatment and management of diabetic retinopathy
  7. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration
  8. Hydrophilic Polymers for Modified-Release Nanoparticles: A Review of Mathematical Modelling for Pharmacokinetic Analysis
  9. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models
  10. Silica-based matrices: State of the art and new perspectives for therapeutic drug delivery
  11. Self-assembling systems based on quaternized derivatives of 1,4-diazabicyclo[2.2.2]octane in nutrient broth as antimicrobial agents and carriers for hydrophobic drugs
  12. Essential Oils as Active Ingredients of Lipid Nanocarriers for Chemotherapeutic Use
  13. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy
  14. Chitosan Cross-Linked Pentasodium Tripolyphosphate Micro/Nanoparticles Produced by Ionotropic Gelation
  15. Effect of cryoprotectants on the reconstitution of silica nanoparticles produced by sol–gel technology
  16. Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate
  17. Surface engineering of silica nanoparticles for oral insulin delivery: Characterization and cell toxicity studies
  18. Development and evaluation of lipid nanocarriers for quercetin delivery: A comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE)
  19. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation
  20. insulin delivery
  21. Cationic solid lipid nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells
  22. Solid lipid nanoparticles for hydrophilic biotech drugs: Optimization and cell viability studies (Caco-2 & HEPG-2 cell lines)
  23. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data
  24. Novel Neuroprotective Formulations Based on St. John’s Wort Extract
  25. Schistosoma manson
  26. Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity
  27. Using nanoparticles to get the most out of antioxidants in food
  28. Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles
  29. Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying
  30. Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer
  31. Nanoemulsions for delivery of flavonoids: formulation andin vitrorelease of rutin as model drug
  32. Characterization and shelf life of β-carotene loaded solid lipid microparticles produced with stearic acid and sunflower oil
  33. Expert Opinion
  34. Influence of lipids on the properties of solid lipid nanoparticles from microemulsion technique
  35. Nanoparticles for Drug Delivery of Small Molecules
  36. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles
  37. Solid Lipid Nanoparticles (SLN™)
  38. Encapsulation of Antioxidants in Gastrointestinal-Resistant Nanoparticulate Carriers
  39. Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process
  40. Brain delivery of camptothecin by means of solid lipid nanoparticles: Formulation design, in vitro and in vivo studies
  41. Optimizing SLN and NLC by 22 full factorial design: Effect of homogenization technique
  42. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies
  43. Editorial [Hot Topic Nanoparticulates for Improved Treatment of Severe Skin Diseases (Guest Editors: Eliana B. Souto, Aristoteles Rosmaninho and Tatiana Andreani)]
  44. Topical Targeting Therapies for Sexually Transmitted Diseases
  45. Preparation of gastro-resistant pellets containing chitosan microspheres for improvement of oral didanosine bioavailability
  46. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles
  47. Lipid Matrix Nanoparticles in Diabetes
  48. Improved and Safe Transcorneal Delivery of Flurbiprofen by NLC and NLC-Based Hydrogels
  49. Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC
  50. Translating Nanotechnology from Bench to Pharmaceutical Market: Barriers, Success, and Promises
  51. Patenting Nanomedicines
  52. Nanomedicines for Immunization and Vaccines
  53. Intellectual Property and Nanopharmaceuticals
  54. Sol–Gel Carrier System: A Novel Controlled Drug Delivery
  55. Desenvolvimento, produção e caracterização de nanocristais de fármacos pouco solúveis
  56. Preparação de nanopartículas poliméricas a partir de polímeros pré-formados: parte II
  57. Preparação de nanopartículas poliméricas a partir da polimerização de monômeros: parte I
  58. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
  59. Hydrophilic coating of mitotane-loaded lipid nanoparticles: Preliminary studies for mucosal adhesion
  60. Loading of praziquantel in the crystal lattice of solid lipid nanoparticles
  61. Polymorphism, crystallinity and hydrophilic–lipophilic balance of stearic acid and stearic acid–capric/caprylic triglyceride matrices for production of stable nanoparticles
  62. Elastic liposomes containing benzophenone-3 for sun protection factor enhancement
  63. Crystallinity of Dynasan®114 and Dynasan®118 matrices for the production of stable Miglyol®-loaded nanoparticles
  64. Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)
  65. Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
  66. Analysis of phase transition and dehydration processes of nevirapine
  67. Editorial [Hot topic: An Overview on the Design, Development, Characterization and Applications of Novel Nanomedicines for Brain Targeting (Guest Editor: Eliana B. Souto)]
  68. Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
  69. Nanopartículas de lipídios sólidos: métodos clássicos de produção laboratorial
  70. Polímeros sintéticos biodegradáveis: matérias-primas e métodos de produção de micropartículas para uso em drug delivery e liberação controlada
  71. Polímeros usados como sistemas de transporte de princípios ativos
  72. Curcuminoids-loaded lipid nanoparticles: Novel approach towards malaria treatment
  73. Nanoparticulate strategies for effective delivery of poorly soluble therapeutics
  74. Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs
  75. Current efforts and the potential of nanomedicine in treating fungal keratitis
  76. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC)
  77. Nanomedicines for ocular NSAIDs: safety on drug delivery
  78. Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes
  79. A Special Issue on Lipid-Based Delivery Systems (Liposomes, Lipid Nanoparticles, Lipid Matrices and Medicines)
  80. A Note on Regulatory Concerns and Toxicity Assessment in Lipid-Based Delivery Systems (LDS)
  81. Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation
  82. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review
  83. Solid Lipid Nanoparticle Formulations: Pharmacokinetic and Biopharmaceutical Aspects in Drug Delivery
  84. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC
  85. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology
  86. Physicochemical characterization andin vitrorelease studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels)
  87. Production of Biofunctionalized Solid Lipid Nanoparticles for Site-specific Drug Delivery
  88. Characterization of ibuprofen loaded solid lipid nanoparticles dispersed in semi-solid Carbopol gels
  89. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10 – Development, physicochemical characterization and in vitro release studies
  90. Insulin-loaded alginate microspheres for oral delivery – Effect of polysaccharide reinforcement on physicochemical properties and release profile
  91. Lipid Nanoparticles (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers) for Cosmetic, Dermal, and Transdermal Applications
  92. Lipid Nanoparticle-Based Systems for Delivery of Biomacromolecule Therapeutics